Velarion Records
Free. Unsubscribe any time.

Kiniksa Pharmaceuticals International, plc (KNSA)

Kiniksa Pharmaceuticals International, plc filed 61 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 7 reporting owners, covering 97 transactions and 2,316,236 shares. None carries the SEC's AFF10B5ONE flag; all 61 name a plan in a footnote. 9 results prints are on file in the same window.

What stands out

Trades in Kiniksa Pharmaceuticals International, plc 97

Adoption dates in Kiniksa Pharmaceuticals International, plc 0

Results prints in Kiniksa Pharmaceuticals International, plc 9

Trades before a print in Kiniksa Pharmaceuticals International, plc 11

Interval to Kiniksa Pharmaceuticals International, plc’s next reported results date

How the interval and sources are counted →

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.